Dimensional Fund Advisors Ltd disclosed a sale of 730,460 ordinary shares of Beazley PLC, reducing its holding to 0.89% as of June 30, 2026. This transaction reflects a partial exit from their investment in Beazley PLC. The sale price per share was approximately £12.87. Investors should watch for further moves by institutional holders as they may influence Beazley's stock performance.
The global pyrometer market, valued at $544.55 million in 2025, is projected to reach $1.15 billion by 2035, growing at a CAGR of 7.57%. This growth is fueled by rising industrial automation and expansion in semiconductor manufacturing, which increas...
Abeona Therapeutics announced it granted restricted stock awards to five new non-executive employees as an inducement to join the company, totaling up to 9,000 shares. These shares will vest over three years, contingent on continued employment. This ...
Holzer & Holzer, LLC announced deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against BitGo Holdings, ADMA Biologics, and Erasca. The lawsuits allege these companies made false or misleading statements affe...
Step Pharma has appointed Neil J. Gallagher, MD, PhD, as a Non-Executive Director to strengthen its board as it advances dencatistat, a first-in-class CTPS1 inhibitor targeting essential thrombocythaemia, lymphoma, and solid tumours. Gallagher brings...
Ocular Therapeutix announced its participation in multiple scientific and investor conferences in July 2026, including presentations on its investigational retinal drug AXPAXLI and real-world data on anti-VEGF treatments. Key events include the OIS R...
